3Liu Yong,Chen Li,Peng Shu-you,Chen Zhou-xun,C Hoang-Vu. Role of CD97stalk and CD55 as molecular markers for prognosis and therapy of gastric carcinoma patients[J] 2005,Journal of Zhejiang University SCIENCE A(9):913～918
3Mcknight A J, Gordon S. The EGF-TM7 family:unsual structures at the leukocyte surface [J]. J Leukoc Biol, 1998,63(3) :271-280.
4Kwakkenbos M J, Kop EN, Stacey M, et al. The human EGF-TM7 family: a postgenomic view [J].Immunogenetics, 2004,55 (10) : 655 - 666.
5Leemans JC, Te Velde AA, Florquin S, et al. The epidermal growth factor-Seven transmembrane (EGFTM7 ) receptor CD97 is required for neutrophil migration and host defense [J]. J Immunol, 2004,172(2):1125-1131.
6Niehans GA, Cherwitz DL, Staley NA, et al. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55(decay-accelerating factor ), and CD59 (protectin)[J]. Am JPathol,1996,149(1):129-142.
7Hamann J, Vogel B, van Schijndel GM, et al. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF) [J]. J Exp Med, 1996,184(3) :1185-1189.
8Jaspars LH,Vos W, Aust G,et al. Tissue distribution of the human CD97 EGF-TM7 receptor [J]. Tissue Antigens, 2001,57(4) : 325-331.
9Aust G, Steinert M, Schutz A, et al. CD97, but not its closely related EGF-TM7 family member EMR2,is expressed on gastric, pancreatic, and esophageal carcinomas [J]. Am J Clin Pathol, 2002,118 (5) : 699-707.
10Steinert M, Wobus M, Boltze C, et al. Expression and regulation of CD97 in colorectal carcinoma cell lines and tumor tissues [J]. Am J Pathol, 2002,161(5):1657-1667.
